GeneMatrix Inc (109820) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.13x

GeneMatrix Inc (109820) has a Cash Flow Reinvestment Rate of 0.13x as of September 2025, reinvesting ₩63.17 Million (capex ₩23.65 Million plus investments ₩-39.52 Million) from operating cash flow of ₩500.19 Million. See GeneMatrix Inc (109820) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.13x
(Capex + Investments) / Operating CF

Total Reinvested

₩63.17 Million
Capex + Investments

Operating Cash Flow

₩500.19 Million
KRW

Capital Expenditures

₩23.65 Million
KRW

GeneMatrix Inc Cash Flow Reinvestment Rate (2020–2021)

Historical reinvestment intensity for GeneMatrix Inc across 2 annual periods. For the full cash flow conversion analysis, see 109820 cash flow conversion.

Annual Cash Flow Reinvestment Rate for GeneMatrix Inc (2020–2021)

Year-by-year capital reinvestment analysis for GeneMatrix Inc. See GeneMatrix Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2021 0.31x ₩1.04 Billion ₩3.37 Billion ₩258.22 Million ▼ -15.2%
2020 0.36x ₩1.64 Billion ₩4.51 Billion ₩366.56 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow